FindTrial
Sign In

The effect of neoadjuvant chemotherapy on the dose requirement of propofol for inducing the loss of consciousness in patients with breast cancer:

The effect of neoadjuvant chemotherapy on the dose requirement of propofol for inducing the loss of consciousness in patients with breast cancer:

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021428
Enrollment
Unknown
Registered
2019-02-21
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

group N:neoadjuvant chemotherapy
group C:none

Sponsors

Jiaxing Maternity and Child Heath Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: scheduled for elective modify radical mastectomy

Exclusion criteria

Exclusion criteria: Subjects with body mass index (BMI) >35 kg/m2, age 60 years, chronic hypertension, or with hepatic dysfunction after neoadjuvant chemotherapy were exclude from this study.

Design outcomes

Primary

MeasureTime frame
ED50;—

Countries

China

Contacts

Public ContactXiao Fei

Jiaxing Maternity and Child Heath Hospital

13706597501@163.com+86 13706597501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026